Innoventric is a medical device company specializing in a novel transcatheter cross-caval approach for treating tricuspid regurgitation (TR). Their Unica™ implant offers a simple, anatomy-agnostic solution designed for safe and effective TR treatment, aiming to expand care to a broader patient population. The company is focused on advancing this technology through clinical trials and has secured significant funding to support its development.